Renal Effects of Adenosine A-Receptor Antagonists in Congestive Heart Failure

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.10, 2001-01, pp. : 1387-1393

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of vasopressin receptor antagonists in congestive heart failure

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 5, 2005-05 ,pp. : 687-691

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V 1A and V 2 receptor antagonist, in dogs with pacing-induced congestive heart failure

By Yatsu T. Tomura Y. Tahara A. Wada K.-i. Kusayama T. Tsukada J. Tokioka T. Uchida W. Inagaki O. Iizumi Y. Tanaka A. Honda K.

European Journal of Pharmacology, Vol. 376, Iss. 3, 1999-07 ,pp. : 239-246

Elsevier

Access to resources Recommend Favorite

Rationale for the Use of Aldosterone Antagonists in Congestive Heart Failure

By Rocha R.

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 723-731

Adis International

Access to resources Recommend Favorite

Heart failure and endothelin receptor antagonists

By Miyauchi T. Goto K.

Trends in Pharmacological Sciences, Vol. 20, Iss. 5, 1999-05 ,pp. : 210-217

Elsevier

Access to resources Recommend Favorite

Vasopressin receptor antagonists in heart failure

By Thibonnier M.

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 683-687

Elsevier

Access to resources Recommend Favorite